CCM - Concord Medical Services Holdings Limited
| Previous close | 1.3300 |
| Open | 1.2400 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 800 |
| Day's range | 1.3950 - 1.4150 |
| 52-week range | 1.0300 - 2.1000 |
| Volume | |
| Avg. volume | 1,804 |
| Market cap | 61.218M |
| Beta (5Y monthly) | -0.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5500 |
| Earnings date | 23 Sept 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 23 Dec 2015 |
| 1y target est | N/A |
Simply Wall St.Concord Medical Services Holdings (NYSE:CCM) shareholders are up 18% this past week, but still in the red over the last five years
This week we saw the Concord Medical Services Holdings Limited ( NYSE:CCM ) share price climb by 18%. But don't envy...
- Simply Wall St.
Concord Medical Services Holdings Full Year 2022 Earnings: CN¥5.61 loss per share (vs CN¥18.79 loss in FY 2021)
Concord Medical Services Holdings ( NYSE:CCM ) Full Year 2022 Results Key Financial Results Revenue: CN¥472.1m (down...
PR NewswireConcord Medical Files 2022 Annual Report on Form 20-F
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 (the "Annual Report") with the U.S. Securities and Exchange Commissio
PR NewswireConcord Medical Schedules 2022 Annual Meeting of Shareholders
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2022 annual general meeting of shareholders (the "Meeting") on December 30, 2022, at 10:00 a.m. (Beijing Time). The meeting will be held
PR NewswireConcord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced the successful holding of the Second Annual Academic Meeting (the "Meeting") jointly by Shanghai Concord Cancer Center and The University of Texas MD Anderson
PR NewswireConcord Medical Announces Changes in Management
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced changes in its management.
PR NewswireConcord Medical Reports Financial Results for the First Half of 2022
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2022[1].